Compare, Analyse ASTRAZENECA PHARMA with ACTAVIS INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ASTRAZENECA PHARMA vs ACTAVIS (US) - Comparison Results

ASTRAZENECA PHARMA     Change

AstraZeneca Pharma India Limited (APIL) is a 90% subsidiary of the UK based AstraZeneca Pharmaceuticals, which is one of the world's leading pharma companies. APIL has interests in the six crucial areas of cardiovascular, respiratory, maternal health... More

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ASTRAZENECA PHARMA   ACTAVIS
EQUITY SHARE DATA
    ASTRAZENECA PHARMA
Mar-18
ACTAVIS
Dec-18
ASTRAZENECA PHARMA/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs1,27813,783-   
Low Rs8839,246-   
Sales per share (Unadj.) Rs228.43,381.0-  
Earnings per share (Unadj.) Rs10.4-1,089.0-  
Cash flow per share (Unadj.) Rs16.3356.3-  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs98.813,944.9-  
Shares outstanding (eoy) m25.00332.60-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.73.4 138.9%   
Avg P/E ratio x104.2-10.6 -985.8%  
P/CF ratio (eoy) x66.432.3 205.6%  
Price / Book Value ratio x10.90.8 1,324.6%  
Dividend payout %00-   
Avg Mkt Cap Rs m27,0083,829,666 0.7%   
No. of employees `0001.416.9 8.0%   
Total wages/salary Rs m1,5350-   
Avg. sales/employee Rs Th4,210.966,538.9 6.3%   
Avg. wages/employee Rs Th1,132.20-   
Avg. net profit/employee Rs Th191.1-21,432.2 -0.9%   
INCOME DATA
Net Sales Rs m5,7101,124,508 0.5%  
Other income Rs m12321,504 0.6%   
Total revenues Rs m5,8331,146,012 0.5%   
Gross profit Rs m46329,468 1.6%  
Depreciation Rs m147480,703 0.0%   
Interest Rs m064,891 0.0%   
Profit before tax Rs m438-494,621 -0.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0126,148 0.0%   
Tax Rs m179-6,268 -2.9%   
Profit after tax Rs m259-362,205 -0.1%  
Gross profit margin %8.12.6 309.4%  
Effective tax rate %40.81.3 3,223.0%   
Net profit margin %4.5-32.2 -14.1%  
BALANCE SHEET DATA
Current assets Rs m3,209461,214 0.7%   
Current liabilities Rs m2,070408,005 0.5%   
Net working cap to sales %20.04.7 421.8%  
Current ratio x1.61.1 137.2%  
Inventory Days Days7220 369.3%  
Debtors Days Days3566 52.7%  
Net fixed assets Rs m790127,288 0.6%   
Share capital Rs m500-   
"Free" reserves Rs m2,4190-   
Net worth Rs m2,4694,638,070 0.1%   
Long term debt Rs m01,633,233 0.0%   
Total assets Rs m4,6057,250,359 0.1%  
Interest coverage xNM-6.6-  
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x1.20.2 799.4%   
Return on assets %5.6-4.1 -137.2%  
Return on equity %10.5-7.8 -134.4%  
Return on capital %17.7-4.8 -366.4%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m-1,7150-   
CASH FLOW
From Operations Rs m88401,744 0.0%  
From Investments Rs m-94220,706 -0.0%  
From Financial Activity Rs mNA-689,514 0.0%  
Net Cashflow Rs m-6-66,728 0.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 71.23 Rs / USD

Compare ASTRAZENECA PHARMA With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare ASTRAZENECA PHARMA With: STRIDES PHARMA SCIENCE  ABBOTT INDIA  FDC LTD.  NOVARTIS  SUN PHARMA  



Today's Market

Sensex Ends 292 Points Higher; Automobile and Metal Stocks Witness Buying(Closing)

After opening the day marginally higher, Indian share markets witnessed buying interest throughout the day and ended on a strong note.

Related Views On News

ASTRAZENECA PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 236.5% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, ASTRAZENECA PHARMA has posted a net profit of Rs 215 m (up 236.5% YoY). Sales on the other hand came in at Rs 2 bn (up 26.7% YoY). Read on for a complete analysis of ASTRAZENECA PHARMA's quarterly results.

ASTRAZENECA PHARMA Announces Quarterly Results (4QFY19); Net Profit Up 204.9% (Quarterly Result Update)

May 27, 2019 | Updated on May 27, 2019

For the quarter ended March 2019, ASTRAZENECA PHARMA has posted a net profit of Rs 98 m (up 204.9% YoY). Sales on the other hand came in at Rs 2 bn (up 26.3% YoY). Read on for a complete analysis of ASTRAZENECA PHARMA's quarterly results.

ASTRAZENECA PHARMA 2017-18 Annual Report Analysis (Annual Result Update)

Mar 29, 2019 | Updated on Mar 29, 2019

Here's an analysis of the annual report of ASTRAZENECA PHARMA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of ASTRAZENECA PHARMA. Also includes updates on the valuation of ASTRAZENECA PHARMA.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound (Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound? (The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

Rebound Riches Could be Yours With These Stocks (Profit Hunter)

Oct 4, 2019

The secret to multibagger is not big businesses, but great managements... Here's how to find them to make the most of once in a decade rebound opportunity.

The One Stock I Like in this Market (The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound (The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ASTRAZENECA PHARMA SHARE PRICE


Oct 15, 2019 (Close)

TRACK ASTRAZENECA PHARMA

  • Track your investment in ASTRAZENECA PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ASTRAZENECA PHARMA

ASTRAZENECA PHARMA - LUPIN COMPARISON

COMPARE ASTRAZENECA PHARMA WITH

MARKET STATS